Local treatment of liver cancer: Ablation or resection?

Yaoping SHI; Bo ZHAI

doi:10.3969/j.issn.1001-5256.2021.03.003

Volume 37 Issue 3

Mar. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2021 > 37(3): 506-509

PDF( 1800 KB)

Local treatment of liver cancer: Ablation or resection?

DOI: 10.3969/j.issn.1001-5256.2021.03.003

Yaoping SHI,
Bo ZHAI^,

Department of Interventional Radiology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China

Received Date: 2021-02-18
Accepted Date: 2021-02-18
Published Date: 2021-03-20

Abstract

Abstract

Liver cancer is one of the most common malignant tumors in China. Surgical resection is still the preferred radical treatment method for patients with liver cancer; however, most patients cannot tolerate surgical resection due to the influence of tumor size, tumor location, liver function, and general condition. In recent years, local ablation techniques, such as radiofrequency ablation and microwave ablation, have developed rapidly and are widely used in clinical practice, and they are even known as new techniques comparable to surgical resection for the radical treatment of liver cancer. This article briefly introduces the application and selection of local ablation and surgical resection in the treatment of liver cancer.
- Liver Neoplasms,
- Ablation Techniques,
- Hepatectomy

FullText(HTML)

References(44)

References

[1]	GEYIK S, AKHAN O, ABBASOGLU O, et al. Radiofrequency ablation of unresectable hepatic tumors[J]. Diagn Interv Radiol, 2006, 12(4): 195-200. http://www.ncbi.nlm.nih.gov/pubmed/11503676
[2]	POGGI G, TOSORATTI N, MONTAGNA B, et al. Microwave ablation of hepatocellular carcinoma[J]. World J Hepatol, 2015, 7(25): 2578-2589. DOI: 10.4254/wjh.v7.i25.2578
[3]	THANOS, L, POULOU LS, ZIAKAS PD, et al. Image-guided radiofrequency ablation (RFA) of unresectable hepatic tumors using a triple-spiral-shaped electrode needle: Initial experience in 34 patients[J]. Cardiovasc Intervent Radiol, 2010, 33(1): 107-112. DOI: 10.1007/s00270-009-9649-9
[4]	VIBERT E, SCHWARTZ M, OLTHOFF KM. Advances in resection and transplantation for hepatocellular carcinoma[J]. J Hepatol, 2020, 72(2): 262-276. DOI: 10.1016/j.jhep.2019.11.017
[5]	PINNA AD, YANG T, MAZZAFERRO V, et al. Liver transplantation and hepatic resection can achieve cure for hepatocellular carcinoma[J]. Ann Surg, 2018, 268(5): 868-875. DOI: 10.1097/SLA.0000000000002889
[6]	CHACKO S, SAMANTA S. Hepatocellular carcinoma: A life-threatening disease[J]. Biomed Pharmacother, 2016, 84: 1679-1688. DOI: 10.1016/j.biopha.2016.10.078
[7]	OGATA S, BELGHITI J, FARGES O, et al. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma[J]. Br J Surg, 2006, 93(9): 1091-1098. DOI: 10.1002/bjs.5341
[8]	ISHIZAWA T, HASEGAWA K, AOKI T, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma[J]. Gastroenterology, 2008, 134(7): 1908-1916. DOI: 10.1053/j.gastro.2008.02.091
[9]	FUKS D, DOKMAK S, PARADIS V, et al. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: An intention-to-treat analysis[J]. Hepatology, 2012, 55(1): 132-140. DOI: 10.1002/hep.24680
[10]	BRUIX J, SHERMAN M, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma[J]. Hepatology, 2005, 42(5): 1208-1236. DOI: 10.1002/hep.20933
[11]	HUANG J, YAN L, CHENG Z, et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria[J]. Ann Surg, 2010, 252(6): 903-912. DOI: 10.1097/SLA.0b013e3181efc656
[12]	BREEN DJ, LENCIONI R. Image-guided ablation of primary liver and renal tumours[J]. Nat Rev Clin Oncol, 2015, 12(3): 175-186. DOI: 10.1038/nrclinonc.2014.237
[13]	AHMED M, BRACE CL, LEE FT Jr, et al. Principles of and advances in percutaneous ablation[J]. Radiology, 2011, 258(2): 351-369. DOI: 10.1148/radiol.10081634
[14]	YU NC, RAMAN SS, KIM YJ, et al. Microwave liver ablation: Influence of hepatic vein size on heat-sink effect in a porcine model[J]. J Vasc Interv Radiol, 2008, 19(7): 1087-1092. DOI: 10.1016/j.jvir.2008.03.023
[15]	SCHRAMM W, YANG D, WOOD BJ, et al. Contribution of direct heating, thermal conduction and perfusion during radiofrequency and microwave ablation[J]. Open Biomed Eng J, 2007, 1: 47-52. DOI: 10.2174/1874120700701010047
[16]	SHIBATA T, ⅡMURO Y, YAMAMOTO Y, et al. Small hepatocellular carcinoma: Comparison of radio-frequency ablation and percutaneous microwave coagulation therapy[J]. Radiology, 2002, 223(2): 331-337. DOI: 10.1148/radiol.2232010775
[17]	LU MD, XU HX, XIE XY, et al. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: A retrospective comparative study[J]. J Gastroenterol, 2005, 40(11): 1054-1060. DOI: 10.1007/s00535-005-1671-3
[18]	QIAN GJ, WANG N, SHEN Q, et al. Efficacy of microwave versus radiofrequency ablation for treatment of small hepatocellular carcinoma: Experimental and clinical studies[J]. Eur Radiol, 2012, 22(9): 1983-1990. DOI: 10.1007/s00330-012-2442-1
[19]	YU J, YU XL, HAN ZY, et al. Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: A phase Ⅲ randomised controlled trial[J]. Gut, 2017, 66(6): 1172-1173. DOI: 10.1136/gutjnl-2016-312629
[20]	LIU Y, ZHENG Y, LI S, et al. Percutaneous microwave ablation of larger hepatocellular carcinoma[J]. Clin Radiol, 2013, 68(1): 21-26. DOI: 10.1016/j.crad.2012.05.007
[21]	XU LF, SUN HL, CHEN YT, et al. Large primary hepatocellular carcinoma: Transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy[J]. J Gastroenterol Hepatol, 2013, 28(3): 456-463. DOI: 10.1111/jgh.12088
[22]	ABDELAZIZ AO, NABEEL MM, ELBAZ TM, et al. Microwave ablation versus transarterial chemoembolization in large hepatocellular carcinoma: Prospective analysis[J]. Scand J Gastroenterol, 2015, 50(4): 479-484. DOI: 10.3109/00365521.2014.1003397
[23]	COPPER IS. Cryogenic surgery: A new method of destruction or extirpation of benign or malignant tissues[J]. N Engl J Med, 1963, 268: 743-749. DOI: 10.1056/NEJM196304042681401
[24]	JUNGRAITHMAYR W, BURGER D, OLSCHEWSKI M, et al. Cryoablation of malignant liver tumors: Results of a single center study[J]. Hepatobiliary Pancreat Dis Int, 2005, 4(4): 554-560. http://qikan.cqvip.com/Qikan/Article/Detail?id=1003033805
[25]	SEIFERT JK, MORRIS DL. World survey on the complications of hepatic and prostate cryotherapy[J]. World J Surg, 1999, 23(2): 109-113; discussion 113-114.
[26]	SMITH MT, RAY CE. The treatment of primary and metastatic hepatic neoplasms using percutaneous cryotherapy[J]. Semin Intervent Radiol, 2006, 23(1): 39-46. DOI: 10.1055/s-2006-939840
[27]	BILCHIK AJ, WOOD TF, ALLEGRA D, et al. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: A proposed algorithm[J]. Arch Surg, 2000, 135(6): 657-662; discussion 662-664.
[28]	GOLDBERG SN, GRASSI CJ, CARDELLA JF, et al. Image-guided tumor ablation: Standardization of terminology and reporting criteria[J]. J Vasc Interv Radiol, 2009, 20(7 Suppl): s377-s390. http://www.sciencedirect.com/science/article/pii/s1051044314008458
[29]	PACELLA CM, BIZZARRI G, FRANCICA G, et al. Analysis of factors predicting survival in patients with hepatocellular carcinoma treated with percutaneous laser ablation[J]. J Hepatol, 2006, 44(5): 902-909. DOI: 10.1016/j.jhep.2006.01.031
[30]	FRANCICA G, PETROLATI A, di STASIO E, et al. Effectiveness, safety, and local progression after percutaneous laser ablation for hepatocellular carcinoma nodules up to 4 cm are not affected by tumor location[J]. AJR Am J Roentgenol, 2012, 199(6): 1393-1401. DOI: 10.2214/AJR.11.7850
[31]	PACELLA CM, BIZZARRI G, FRANCICA G, et al. Percutaneous laser ablation in the treatment of hepatocellular carcinoma with small tumors: Analysis of factors affecting the achievement of tumor necrosis[J]. J Vasc Interv Radiol, 2005, 16(11): 1447-1457. DOI: 10.1097/01.RVI.90000172121.82299.38
[32]	POMPILI M, PACELLA CM, FRANCICA G, et al. Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation[J]. Eur J Radiol, 2010, 74(3): e6-e11. DOI: 10.1016/j.ejrad.2009.03.012
[33]	LENCIONI R, CIONI D, DELLA PINA C, et al. Hepatocellular carcinoma: New options for image-guided ablation[J]. J Hepatobiliary Pancreat Sci, 2010, 17(4): 399-403. DOI: 10.1007/s00534-009-0233-0
[34]	NARAYANAN G. Irreversible electroporation for treatment of liver cancer[J]. Gastroenterol Hepatol (N Y), 2011, 7(5): 313-316. http://www.ncbi.nlm.nih.gov/pubmed/21857833
[35]	MAOR E, IVORRA A, LEOR J, et al. The effect of irreversible electroporation on blood vessels[J]. Technol Cancer Res Treat, 2007, 6(4): 307-312. DOI: 10.1177/153303460700600407
[36]	CHARPENTIER KP, WOLF F, NOBLE L, et al. Irreversible electroporation of the liver and liver hilum in swine[J]. HPB (Oxford), 2011, 13(3): 168-173. DOI: 10.1111/j.1477-2574.2010.00261.x
[37]	Bureau of Medical Administration, National Health Commission of the People's Republic of China. Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)[J]. J Clin Hepatol, 2020, 36(2): 277-292. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2020.05.009 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J]. 临床肝胆病杂志, 2020, 36(2): 277-292. DOI: 10.3969/j.issn.1001-5256.2020.05.009
[38]	CHEN MS, LI JQ, ZHENG Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma[J]. Ann Surg, 2006, 243(3): 321-328. DOI: 10.1097/01.sla.0000201480.65519.b8
[39]	FANG Y, CHEN W, LIANG X, et al. Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 2014, 29(1): 193-200. DOI: 10.1111/jgh.12441
[40]	NG K, CHOK K, CHAN A, et al. Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma[J]. Br J Surg, 2017, 104(13): 1775-1784. DOI: 10.1002/bjs.10677
[41]	LAU WY, LAI EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: A systematic review[J]. Ann Surg, 2009, 249(1): 20-25. DOI: 10.1097/SLA.0b013e31818eec29
[42]	PENG ZW, ZHANG YJ, CHEN MS, et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: A prospective randomized trial[J]. J Clin Oncol, 2013, 31(4): 426-432. DOI: 10.1200/JCO.2012.42.9936
[43]	MORIMOTO M, NUMATA K, KONDOU M, et al. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: A randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization[J]. Cancer, 2010, 116(23): 5452-5460. DOI: 10.1002/cncr.25314
[44]	KAGAWA T, KOIZUMI J, KOJIMA S, et al. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: Comparison with surgical resection[J]. Cancer, 2010, 116(15): 3638-3644. DOI: 10.1002/cncr.25142

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (456) PDF downloads(82)

Local treatment of liver cancer: Ablation or resection?

DOI: 10.3969/j.issn.1001-5256.2021.03.003

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Local treatment of liver cancer: Ablation or resection?

DOI: 10.3969/j.issn.1001-5256.2021.03.003

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content